Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Detection
IMI reports development progress on three cancer-detection tests
December 26th, 2002
Predictive medicine company IMI International Medical Innovations, Inc., (TSX:IMI) reported progress on its development and clinical testing of the company's three lead cancer- detection tests that are based on the same marker and core technology: ColorectAlert for colorectal cancer, LungAlert for lung cancer and a new test for breast cancer. Upon completion of the analysis of studies involving each of the three cancer tests the company will publicly release the detailed data to coincide with publication or presentation of the findings to the medical community. ColorectAlert is a minimally invasive screening test for colorectal cancer that identifies...
Source: Women's Health Weekly (2002-12-26)
|
